CLOV insider plans Rule 144 stock sale

Jamie Reynoso reports an intention under Rule 144 to sell up to 4,839 shares of CLOV common stock through Morgan Stanley Smith Barney LLC, with an indicated value of $21,291.60.

Accepted by SEC EDGAR 07/17/2026 - 04:19 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jamie Reynoso reports an intention under Rule 144 to sell up to 4,839 shares of CLOV common stock through Morgan Stanley Smith Barney LLC, with an indicated value of $21,291.60. The notice also lists multiple prior common-stock sales between June 11 and July 15, 2026, some under 10b5-1 plans.

Key Figures

Planned shares to be sold: 4,839 shares Planned sale value: $21,291.60 Sale on 07/15/2026: 13,119 shares; $61,265.73 +1 more

4 metrics

Planned shares to be sold 4,839 shares Common stock proposed for sale under Rule 144

Planned sale value $21,291.60 Indicated value of 4,839 CLOV shares in planned Rule 144 sale

Sale on 07/15/2026 13,119 shares; $61,265.73 CLOV common stock sold by Jamie Reynoso on July 15, 2026

Sale on 06/11/2026 7,289 shares; $35,752.71 CLOV common stock sold by Jamie Reynoso on June 11, 2026

Key Terms

Rule 144, Restricted Stock Units, 10b5-1 Sales

3 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 07/15/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLOV Form 144 notice disclose?

The notice discloses that Jamie Reynoso intends to sell up to 4,839 shares of CLOV common stock under Rule 144 through Morgan Stanley Smith Barney LLC, and lists several prior stock sales over the previous three months.

How many CLOV shares is Jamie Reynoso planning to sell under Rule 144?

Jamie Reynoso plans to sell up to 4,839 shares of CLOV common stock. The planned sale is routed through Morgan Stanley Smith Barney LLC, with the shares valued at $21,291.60 at the time of the notice.

What recent CLOV stock sales by Jamie Reynoso are listed?

Listed sales include 13,119 shares for $61,265.73 on July 15, 2026, plus several earlier June and July 2026 transactions in CLOV common stock, some identified specifically as 10b5-1 Sales.

What is the role of Morgan Stanley Smith Barney LLC in the CLOV Form 144?

Morgan Stanley Smith Barney LLC is listed as the broker handling the planned Rule 144 transaction, associated with the proposed sale of 4,839 CLOV common shares valued at $21,291.60 as of the notice.

Are the CLOV stock sales by Jamie Reynoso made under a 10b5-1 plan?

Some, but not all, of the listed transactions are labeled as 10b5-1 Sales. Specific entries in June and July 2026 identify themselves that way, indicating those particular trades followed a pre-arranged trading plan.

What type of CLOV securities are involved in Jamie Reynoso’s planned sale?

The Form 144 relates to common stock of CLOV, associated with Restricted Stock Units dated July 15, 2026, and routed for sale through Morgan Stanley Smith Barney LLC under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839066
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	JAMIE REYNOSO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4839	21291.60	430969398	07/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2026	Restricted Stock Units	Issuer			4839	07/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/15/2026	13119	61265.73
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/08/2026	2384	11153.07
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/06/2026	6229	32764.54
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	06/17/2026	2360	11275.61
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	06/15/2026	6350	29273.50
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	06/11/2026	7289	35752.71

144: Remarks and Signature

Remarks
Date of Notice	07/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jamie Reynoso
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)